ArticleLancet (London, England)2022
Waning of COVID-19 vaccine effectiveness: individual and public health risk.
Article in Lancet (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial.The Lancet. Respiratory medicine · 2022Trial
- European countries policy responses against SARS-Cov-2 in the context of vaccinations.Scientific reports · 2025Article
- Prenatal Maternal Immunization for Infant Protection: A Review of the Vaccines Recommended, Infant Immunity and Future Research Directions.Pathogens (Basel, Switzerland) · 2024Review
- An analysis of the waning effect of COVID-19 vaccinations.Genomics & informatics · 2023Article
- A two-arm analysis of the immune response to heterologous boosting of inactivated SARS-CoV-2 vaccines.Scientific reports · 2023Article
- First Do No Harm? Modeling Risks and Benefits of Challenge Trials for Hepatitis C Vaccine Development.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023Article
- Threshold conditions for curbing COVID-19 with a dynamic zero-case policy derived from 101 outbreaks in China.BMC public health · 2023Article
- A population-based paediatric Covid-19 vaccination progress and outcomes: The Malta case.Ethics, medicine, and public health · 2023Article
- "Having vaccines is good but not enough": Requirements for optimal COVID-19 immunization program in Vietnam.Frontiers in public health · 2023Article
- In Vitro Diagnostic Assay to Detect SARS-CoV-2-Neutralizing Antibody in Patient Sera Using Engineered ACE-2 Mini-Protein.Viruses · 2022Article
- Assessing the impact of the four COVID-19 variants and the vaccine coverage on mortality in Malta over 2 years: An observational case study.Frontiers in public health · 2022Observational
- Immune-related adverse events of biological immunotherapies used in COVID-19.Frontiers in pharmacology · 2022Review
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.